Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-09 09:22 am Purchase | 13G | NABRIVA THERAPEUTICS PLC NBRVF | FMR LLC | 2,215,958 3.847% | 786,699 (+55.04%) | View |
| 2021-11-19 12:57 pm Purchase | 13G | NABRIVA THERAPEUTICS PLC NBRVF | Lincoln Park Capital Fund LLC | 4,512,589 7.960% | 4,512,589 (New Position) | View |
| 2021-02-08 10:35 am Purchase | 13G | NABRIVA THERAPEUTICS PLC NBRVF | FMR LLC | 1,429,259 6.780% | 1,429,259 (New Position) | View |
| 2020-02-12 4:32 pm Purchase | 13G | NABRIVA THERAPEUTICS PLC NBRVF | Longitude Capital Partners II LLC | 4,256,527 4.500% | 244,152 (+6.08%) | View |
| 2020-02-07 11:26 am Purchase | 13G | NABRIVA THERAPEUTICS PLC NBRVF | FMR LLC | 6,131,900 6.485% | 6,131,900 (New Position) | View |
| 2019-12-26 4:01 pm Unchanged | 13D | NABRIVA THERAPEUTICS PLC NBRVF | ORBIMED ADVISORS LLC | 4,644,600 4.900% | 0 (Unchanged) | View |
| 2019-12-06 4:46 pm Unchanged | 13D | NABRIVA THERAPEUTICS PLC NBRVF | ORBIMED ADVISORS LLC | 4,644,600 5.900% | 0 (Unchanged) | View |